| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/30/2009 | WO2009055074A2 Erbb2 binding proteins and use thereof |
| 04/30/2009 | WO2009055053A2 Diarylhydantoin compounds as androgen receptor modulators |
| 04/30/2009 | WO2009054970A1 Mesylate salt of an ikk inhibitor |
| 04/30/2009 | WO2009054935A1 Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapy |
| 04/30/2009 | WO2009054864A1 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 04/30/2009 | WO2009054747A1 Anti-metastatic agent |
| 04/30/2009 | WO2009054558A1 A method for diagnosing disease using adenovirus harboring trans-splicing ribozyme by molecular imaging |
| 04/30/2009 | WO2009054483A1 Drug containing salusin-β |
| 04/30/2009 | WO2009054471A1 Immune response inducer |
| 04/30/2009 | WO2009054470A1 Immune response inducer and use thereof |
| 04/30/2009 | WO2009054454A1 Regulator for signaling of toll-like receptor, which comprises cathepsin inhibitor as active ingredient |
| 04/30/2009 | WO2009054332A1 Pyridone-substituted-dihydropyrazolopyrimidinone derivative |
| 04/30/2009 | WO2009054001A1 A pharmaceutical composition and a process thereof |
| 04/30/2009 | WO2009053982A1 Constructs containing multiple expression cassettes for cancer therapy |
| 04/30/2009 | WO2009053804A2 Idarubicin for the treatment of lymphoma in a dog |
| 04/30/2009 | WO2009053716A1 Purine derivatives useful as pi3 kinase inhibitors |
| 04/30/2009 | WO2009053715A1 Thienopyrimidiene derivatives as pi3k inhibitors |
| 04/30/2009 | WO2009053694A1 Therapeutic oxy-phenyl-aryl compounds and their use |
| 04/30/2009 | WO2009053654A2 Gemcitabine phosphoester prodrugs as anticancer agents |
| 04/30/2009 | WO2009053644A2 Use of lanthanide-based nanoparticles as radiosensitizing agents |
| 04/30/2009 | WO2009053628A2 Novel compounds, preparation and uses thereof |
| 04/30/2009 | WO2009053467A2 The use of a non-glycanated polypeptide for treating a cancer |
| 04/30/2009 | WO2009053445A2 Polymorphic forms of ibandronate sodium and processes for preparation thereof |
| 04/30/2009 | WO2009053373A1 Quinolinone derivatives as parp inhibitors |
| 04/30/2009 | WO2009053109A1 Antigen-specific t-cell preparations from bone marrow |
| 04/30/2009 | WO2009053102A1 Novel imidazole derivatives |
| 04/30/2009 | WO2009053101A1 Novel imidazole derivatives |
| 04/30/2009 | WO2009053064A1 Sdf-1-based glycosaminoglycan antagonists and methods of using same |
| 04/30/2009 | WO2009053038A2 Combination therapy of a type ii anti-cd20 antibody with a proteasome inhibitor |
| 04/30/2009 | WO2009052711A1 New compounds isolated from extract of antrodia camphorata |
| 04/30/2009 | WO2009052617A1 Treatment regime for proliferative disorders |
| 04/30/2009 | WO2009052561A1 Compositions and methods for manipulating an immune response |
| 04/30/2009 | WO2009033733A3 Use of apeptide as a therapeutic agent |
| 04/30/2009 | WO2009027644A8 Compositions for the treatment of neoplastic diseases |
| 04/30/2009 | WO2009022988A3 Vhz for diagnosis and treatment of cancer |
| 04/30/2009 | WO2009021169A3 (7h-pyrr0l0 [2, 3-d] pyrimidin-4-yl) -piperazines as kinase inhibitors for the treatment of cancer and inflammation |
| 04/30/2009 | WO2009019312A3 Anti cd37 antibodies |
| 04/30/2009 | WO2009013619A3 The ed-a antigen of fibrinogen is associated with the neovas culature of tumor metastases |
| 04/30/2009 | WO2009011910A3 Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatment |
| 04/30/2009 | WO2009011871A3 Thiadiazole modulators of pkb |
| 04/30/2009 | WO2008155387A3 Anti-igf antibodies that bind to igf-1 and igf-2 but not to insulin |
| 04/30/2009 | WO2008140553A4 Mapk/erk kinase inhibitors |
| 04/30/2009 | WO2008140421A3 Heterocycloalkyl substituted pyrimidine derivatives |
| 04/30/2009 | WO2008140420A3 Pyrimidine derivatives |
| 04/30/2009 | WO2008140419A3 Pyridyl substituted pyrimidine derivatives |
| 04/30/2009 | WO2008138889A3 3, 6-disubstituted-imidazo [1, 2-b] pyridazines and 3, 5-disubstituted pyrazolo[1, 5-a] pyrimidines as phosphatidylinositol-3-kinase inhibitors |
| 04/30/2009 | WO2008127594A3 Combination therapies comprising quinoxaline inhibitors of pi3k-alpha for use in the treatment of cancer |
| 04/30/2009 | WO2008126123A3 Water-soluble coronene derivatives active as inhibitors of telomerase |
| 04/30/2009 | WO2008109498A4 Nucleic acid compounds for inhibiting hdac gene expression and uses thereof |
| 04/30/2009 | WO2008094969A3 Combination therapy with angiogenesis inhibitors |
| 04/30/2009 | WO2008094834A3 Multi-functional drug carriers |
| 04/30/2009 | WO2008011710A8 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 04/30/2009 | WO2007059099A3 Boroproline combination therapy for cancer |
| 04/30/2009 | WO2007058850A3 Inhibitors of akt activity |
| 04/30/2009 | WO2007016254A3 Antineoplastic activities of ellipticine and its derivatives |
| 04/30/2009 | WO2007014327A3 Small compounds that correct protein misfolding and uses thereof |
| 04/30/2009 | WO2005010169A3 High throughput or capillary-based screening for a bioactivity or biomolecule |
| 04/30/2009 | WO2004092199A3 Method for identifying modulators of g protein coupled receptor signaling |
| 04/30/2009 | US20090111870 Angelicae Sinensis Extracts Useful for Treatment of Cancers |
| 04/30/2009 | US20090111869 Benzoquinone ansamycins |
| 04/30/2009 | US20090111862 Compound |
| 04/30/2009 | US20090111860 Sulfonamide compounds useful as adg receptor modulators |
| 04/30/2009 | US20090111859 2-(5,5-Dimethylcyclopent-1-enyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane; metabolic disorders such as type II diabetes |
| 04/30/2009 | US20090111845 Treating a cancer or malignant tumor using the crystalline camptothecin ester hydrates; nontoxic |
| 04/30/2009 | US20090111836 Angular Pyranocoumarins, Process for Preparation and Uses Thereof |
| 04/30/2009 | US20090111828 L-alanine derivatives |
| 04/30/2009 | US20090111816 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 04/30/2009 | US20090111802 Cyclocarbamate derivatives as progesterone receptor modulators |
| 04/30/2009 | US20090111799 Anti-infective agents against intracellular pathogens |
| 04/30/2009 | US20090111784 Medication against breast cancer and related diseases |
| 04/30/2009 | US20090111779 Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis |
| 04/30/2009 | US20090111772 Formulation of quinazoline based egfr inhibitors containing a zinc binding moiety |
| 04/30/2009 | US20090111765 Compositions and methods for immunostimulatory rna oligonucleotides |
| 04/30/2009 | US20090111762 Method of diagnosing and treating cancer using b-catenin splice variants |
| 04/30/2009 | US20090111756 Monomethylvaline Compounds Having Phenylalanine Carboxy Modifications at the C-Terminus |
| 04/30/2009 | US20090111738 Fibronectin polypeptides and methods of use |
| 04/30/2009 | US20090110757 Methods for modulating eicosanoid metabolism |
| 04/30/2009 | US20090110753 Enzyme-cleavable prodrug compounds |
| 04/30/2009 | US20090110746 New class of therapeutics that enhance small modecule diffusion |
| 04/30/2009 | US20090110718 Derivatives of tiacumicin B as anti-cancer agents |
| 04/30/2009 | US20090110696 Mycobacterial SecA2 Mutants |
| 04/30/2009 | US20090110687 Compositions and methods related to tim 3, a th1-specific cell surface molecule |
| 04/30/2009 | US20090110681 Anti-M-CSF Antibody Compositions |
| 04/30/2009 | US20090110678 Receptor antagonists for treatment of metastatic bone cancer |
| 04/30/2009 | US20090110677 Polypeptide regulating phosphate metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same |
| 04/30/2009 | US20090110676 BAFF, Inhibitors Thereof and Their Use in the Modulation of B-Cell Response and Treatment of Autoimmune Disorders |
| 04/30/2009 | US20090110666 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours |
| 04/30/2009 | US20090110665 Reovirus for the treatment of neoplasia |
| 04/30/2009 | US20090110659 Immunoglobulin specific to eotaxin for use in diagnosis, prevention and treatment of infections, autoimmune, inflammatory and allergic disorders; chemotactic cytokines designated human eotaxins; selectively modulate leukocyte function |
| 04/30/2009 | US20090110644 Polymer nanoparticles coated by magnetic metal oxide and uses thereof |
| 04/30/2009 | DE102007047737A1 Piperidin- und Piperazinderivate Piperidine and piperazine derivatives |
| 04/30/2009 | DE10128250B4 Neue Glykolipidderivate, Verfahren zu deren Herstellung und diese enthaltende Mittel Glykolipidderivate new, processes for their preparation and compositions comprising them |
| 04/30/2009 | CA2704052A1 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 04/30/2009 | CA2703774A1 Constructs containing multiple expression cassettes for cancer therapy |
| 04/30/2009 | CA2703653A1 Pyridine and pyrazine derivatives -083 |
| 04/30/2009 | CA2703635A1 Diarylhydantoin compounds as androgen receptor modulators |
| 04/30/2009 | CA2703489A1 Pyridone-substituted-dihydropyrazolopyrimidinone derivative |
| 04/30/2009 | CA2703477A1 Tropane compounds |
| 04/30/2009 | CA2703350A1 Immune response inducer |
| 04/30/2009 | CA2703184A1 Inhibition of urokinase-type plasminogen activator (upa) activity |